In recent years, glucagon-like peptide-1 (GLP-1) receptor agonists have gone from obscure type 2 diabetes drugs to headline news for weight loss, polycystic ovary syndrome, and more
The FDA has rigorously tested and approved Tirzepatide for chronic weight management
And even when you can find them, theres the separate issue of affordability
The ATTAIN global phase 3 registration program demonstrated clinically significant and meaningful body weight reduction along with improvements in markers of cardiometabolic disease, such as waist circumference, blood pressure, lipids and highsensitivity Creactive protein, in people with obesity, with and without type 2 diabetes, with an efficacy and safety profile generally similar to injectable incretin-based OMMs 3,9
Confirm the dispensing pharmacy directly with RxSpan MD
Aiding the body's ability to generate fat cell mobilisation so it can be used as energy by the body